Copyright Reports & Markets. All rights reserved.

Global and United States Interleukin 17A Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Interleukin 17A Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Interleukin 17A Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Interleukin 17A Market Size Growth Rate by Type
    • 1.4.2 ABY-035
    • 1.4.3 CNTO-6785
    • 1.4.4 DLX-2882
    • 1.4.5 Others
  • 1.5 Market by Application
    • 1.5.1 Global Interleukin 17A Market Size Growth Rate by Application
    • 1.5.2 Chronic Pain
    • 1.5.3 Liver Cancer
    • 1.5.4 Kidney Cancer
    • 1.5.5 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Interleukin 17A Market Size, Estimates and Forecasts
    • 2.1.1 Global Interleukin 17A Revenue 2015-2026
    • 2.1.2 Global Interleukin 17A Sales 2015-2026
  • 2.2 Global Interleukin 17A, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Interleukin 17A Historical Market Size by Region (2015-2020)
    • 2.3.1 Global Interleukin 17A Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global Interleukin 17A Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 Interleukin 17A Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Interleukin 17A Sales Forecast by Region (2021-2026)
    • 2.4.2 Global Interleukin 17A Revenue Forecast by Region (2021-2026)

3 Global Interleukin 17A Competitor Landscape by Players

  • 3.1 Global Top Interleukin 17A Sales by Manufacturers
    • 3.1.1 Global Interleukin 17A Sales by Manufacturers (2015-2020)
    • 3.1.2 Global Interleukin 17A Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global Interleukin 17A Manufacturers by Revenue
    • 3.2.1 Global Interleukin 17A Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global Interleukin 17A Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Interleukin 17A Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Interleukin 17A Revenue in 2019
    • 3.2.5 Global Interleukin 17A Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global Interleukin 17A Price by Manufacturers
  • 3.4 Global Interleukin 17A Manufacturing Base Distribution, Product Types
    • 3.4.1 Interleukin 17A Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Interleukin 17A Product Type
    • 3.4.3 Date of International Manufacturers Enter into Interleukin 17A Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Interleukin 17A Market Size by Type (2015-2020)
    • 4.1.1 Global Interleukin 17A Sales by Type (2015-2020)
    • 4.1.2 Global Interleukin 17A Revenue by Type (2015-2020)
    • 4.1.3 Interleukin 17A Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Interleukin 17A Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Interleukin 17A Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Interleukin 17A Revenue Forecast by Type (2021-2026)
    • 4.2.3 Interleukin 17A Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Interleukin 17A Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Interleukin 17A Market Size by Application (2015-2020)
    • 5.1.1 Global Interleukin 17A Sales by Application (2015-2020)
    • 5.1.2 Global Interleukin 17A Revenue by Application (2015-2020)
    • 5.1.3 Interleukin 17A Price by Application (2015-2020)
  • 5.2 Interleukin 17A Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Interleukin 17A Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Interleukin 17A Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Interleukin 17A Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application

  • 6.1 United States Interleukin 17A Market Size YoY Growth 2015-2026
    • 6.1.1 United States Interleukin 17A Sales YoY Growth 2015-2026
    • 6.1.2 United States Interleukin 17A Revenue YoY Growth 2015-2026
    • 6.1.3 United States Interleukin 17A Market Share in Global Market 2015-2026
  • 6.2 United States Interleukin 17A Market Size by Players (International and Local Players)
    • 6.2.1 United States Top Interleukin 17A Players by Sales (2015-2020)
    • 6.2.2 United States Top Interleukin 17A Players by Revenue (2015-2020)
  • 6.3 United States Interleukin 17A Historic Market Review by Type (2015-2020)
    • 6.3.1 United States Interleukin 17A Sales Market Share by Type (2015-2020)
    • 6.3.2 United States Interleukin 17A Revenue Market Share by Type (2015-2020)
    • 6.3.3 United States Interleukin 17A Price by Type (2015-2020)
  • 6.4 United States Interleukin 17A Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 United States Interleukin 17A Sales Forecast by Type (2021-2026)
    • 6.4.2 United States Interleukin 17A Revenue Forecast by Type (2021-2026)
    • 6.4.3 United States Interleukin 17A Price Forecast by Type (2021-2026)
  • 6.5 United States Interleukin 17A Historic Market Review by Application (2015-2020)
    • 6.5.1 United States Interleukin 17A Sales Market Share by Application (2015-2020)
    • 6.5.2 United States Interleukin 17A Revenue Market Share by Application (2015-2020)
    • 6.5.3 United States Interleukin 17A Price by Application (2015-2020)
  • 6.6 United States Interleukin 17A Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 United States Interleukin 17A Sales Forecast by Application (2021-2026)
    • 6.6.2 United States Interleukin 17A Revenue Forecast by Application (2021-2026)
    • 6.6.3 United States Interleukin 17A Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America Interleukin 17A Market Size YoY Growth 2015-2026
  • 7.2 North America Interleukin 17A Market Facts & Figures by Country
    • 7.2.1 North America Interleukin 17A Sales by Country (2015-2020)
    • 7.2.2 North America Interleukin 17A Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe Interleukin 17A Market Size YoY Growth 2015-2026
  • 8.2 Europe Interleukin 17A Market Facts & Figures by Country
    • 8.2.1 Europe Interleukin 17A Sales by Country
    • 8.2.2 Europe Interleukin 17A Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Interleukin 17A Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific Interleukin 17A Market Facts & Figures by Country
    • 9.2.1 Asia Pacific Interleukin 17A Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific Interleukin 17A Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America Interleukin 17A Market Size YoY Growth 2015-2026
  • 10.2 Latin America Interleukin 17A Market Facts & Figures by Country
    • 10.2.1 Latin America Interleukin 17A Sales by Country
    • 10.2.2 Latin America Interleukin 17A Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Interleukin 17A Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Interleukin 17A Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Interleukin 17A Sales by Country
    • 11.2.2 Middle East and Africa Interleukin 17A Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 U.A.E

12 Company Profiles

  • 12.1 AbbVie Inc
    • 12.1.1 AbbVie Inc Corporation Information
    • 12.1.2 AbbVie Inc Description and Business Overview
    • 12.1.3 AbbVie Inc Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 AbbVie Inc Interleukin 17A Products Offered
    • 12.1.5 AbbVie Inc Recent Development
  • 12.2 Abeome Corporation
    • 12.2.1 Abeome Corporation Corporation Information
    • 12.2.2 Abeome Corporation Description and Business Overview
    • 12.2.3 Abeome Corporation Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 Abeome Corporation Interleukin 17A Products Offered
    • 12.2.5 Abeome Corporation Recent Development
  • 12.3 Affibody AB
    • 12.3.1 Affibody AB Corporation Information
    • 12.3.2 Affibody AB Description and Business Overview
    • 12.3.3 Affibody AB Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 Affibody AB Interleukin 17A Products Offered
    • 12.3.5 Affibody AB Recent Development
  • 12.4 Cell Medica Limited
    • 12.4.1 Cell Medica Limited Corporation Information
    • 12.4.2 Cell Medica Limited Description and Business Overview
    • 12.4.3 Cell Medica Limited Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 Cell Medica Limited Interleukin 17A Products Offered
    • 12.4.5 Cell Medica Limited Recent Development
  • 12.5 Eli Lilly and Company
    • 12.5.1 Eli Lilly and Company Corporation Information
    • 12.5.2 Eli Lilly and Company Description and Business Overview
    • 12.5.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 Eli Lilly and Company Interleukin 17A Products Offered
    • 12.5.5 Eli Lilly and Company Recent Development
  • 12.6 Johnson & Johnson
    • 12.6.1 Johnson & Johnson Corporation Information
    • 12.6.2 Johnson & Johnson Description and Business Overview
    • 12.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 12.6.4 Johnson & Johnson Interleukin 17A Products Offered
    • 12.6.5 Johnson & Johnson Recent Development
  • 12.7 Merck KGaA
    • 12.7.1 Merck KGaA Corporation Information
    • 12.7.2 Merck KGaA Description and Business Overview
    • 12.7.3 Merck KGaA Sales, Revenue and Gross Margin (2015-2020)
    • 12.7.4 Merck KGaA Interleukin 17A Products Offered
    • 12.7.5 Merck KGaA Recent Development
  • 12.8 Novartis AG
    • 12.8.1 Novartis AG Corporation Information
    • 12.8.2 Novartis AG Description and Business Overview
    • 12.8.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
    • 12.8.4 Novartis AG Interleukin 17A Products Offered
    • 12.8.5 Novartis AG Recent Development
  • 12.9 Orega Biotech SAS
    • 12.9.1 Orega Biotech SAS Corporation Information
    • 12.9.2 Orega Biotech SAS Description and Business Overview
    • 12.9.3 Orega Biotech SAS Sales, Revenue and Gross Margin (2015-2020)
    • 12.9.4 Orega Biotech SAS Interleukin 17A Products Offered
    • 12.9.5 Orega Biotech SAS Recent Development
  • 12.11 AbbVie Inc
    • 12.11.1 AbbVie Inc Corporation Information
    • 12.11.2 AbbVie Inc Description and Business Overview
    • 12.11.3 AbbVie Inc Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 AbbVie Inc Interleukin 17A Products Offered
    • 12.11.5 AbbVie Inc Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Interleukin 17A Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Interleukin 17A Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Interleukin 17A market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Interleukin 17A market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Segment by Type, the Interleukin 17A market is segmented into
    ABY-035
    CNTO-6785
    DLX-2882
    Others

    Segment by Application, the Interleukin 17A market is segmented into
    Chronic Pain
    Liver Cancer
    Kidney Cancer
    Others

    Regional and Country-level Analysis
    The Interleukin 17A market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Interleukin 17A market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

    Competitive Landscape and Interleukin 17A Market Share Analysis
    Interleukin 17A market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Interleukin 17A business, the date to enter into the Interleukin 17A market, Interleukin 17A product introduction, recent developments, etc.
    The major vendors covered:
    AbbVie Inc
    Abeome Corporation
    Affibody AB
    Cell Medica Limited
    Eli Lilly and Company
    Johnson & Johnson
    Merck KGaA
    Novartis AG
    Orega Biotech SAS

    Buy now